Hoth therapeutics regains compliance with nasdaq listing requirements

New york , jan. 24, 2025 /prnewswire/ -- hoth therapeutics, inc. (nasdaq: hoth) (the "company" or "hoth therapeutics"), a biopharmaceutical company, today announced that it has received notification from the listing qualifications department of the nasdaq stock market llc ("nasdaq") that the company has regained compliance with nasdaq's minimum bid price requirement under listing rule 5550(a)(2). the company received written notification from nasdaq on january 23, 2025, stating that because the company's common stock had a closing bid price at or above $1.00 per share for 10 consecutive business days, from january 7, 2025 to january 22, 2025, the company has regained compliance with listing rule 5550(a)(2), and this matter is now closed.
NDAQ Ratings Summary
NDAQ Quant Ranking